Company Marks First Annual Meeting at Historic Perkins Place Office Building as It Prepares to Relocate Its Headquarters from First Horizon Plaza ...

Biopharmaceuticals, also known as biologics, are a class of medicines produced using living systems such as microorganisms, plant or animal cells, or recombinant DNA technology. Unlike traditional ...

Management projected full-year 2025 net product revenues of $140 million to $150 million for OJEMDA, citing "strong and persistent demand, deepening prescriber adoption, and consistent payer coverage" ...

Concussion therapeutics developer surpasses crowdfunding goal reflecting strong investor interest in its clinical-stage ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Identifying biopharmaceuticals with the potential to be formulated as pills just became easier, according to researchers who used artificial intelligence to find drugs stable enough for oral delivery.

Day One Biopharmaceuticals has hired Laura Cooper as head of corporate communications. Cooper started in the role on October 31, reporting to Joey Perrone, SVP of finance and investor relations. The ...

NIJMEGEN, The Netherlands--(BUSINESS WIRE)--Synthon Biopharmaceuticals B.V., a biopharmaceutical research and development company creating innovative precision medicines for patients with relentless ...

Explore how modular facilities and single-use technologies enable scalable, compliant biomanufacturing for global commercial ...

Acquisition expands Servier's position in oncology with tovorafenib marketed as OJEMDATM in the U.S. in pediatric low-grade glioma. Transaction also includes a strong oncology pipeline of clinical ...